NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseNov 10, 2026 3:59:59 PM EST
40.69USD-1.655%(-0.69)6,513,223
Pre-marketNov 10, 2026 9:29:30 AM EST
40.74USD-1.547%(-0.64)
After-hoursNov 10, 2026 4:53:30 PM EST
40.72USD+0.061%(+0.02)
Loading…
Loading…
179.41B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$41.38
Beta
0.97
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$40.50
SMA 200
$43.59
Avg. Vol 10D
13.28M
Avg. Vol 30D
11.89M
Avg. Vol 90D
12.14M
Relative Vol
0.42
4.41B
3.16B
71.57%
37,436,108
1.18%
3.11
55%/45%
41.55%
25.55%
0.2800%
10,000,000
1,902
13,684
121,034
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Nov 10, 2026
Eli Lilly vs Novo Nordisk: What's the Better GLP-1 Stock to Buy? · 
The Motley Fool
Is NVO Undervalued? DCF Says Worth $99 · 
GuruFocus
Hims & Hers: 3 Key Takeaways for Long-Term Investors · The Motley Fool
Nov 9, 2026
Novo Resources Releases Updated Corporate Presentation · 
GlobeNewswire Inc.
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 40.19 | 2026-11-03 | +1.24% | 1.227 |
| 1M | 38.64 | 2026-10-09 | +5.30% | 0.820 |
| 3M | 47.73 | 2026-08-10 | -14.75% | 0.639 |
| 6M | 46.40 | 2026-05-11 | -12.31% | 0.198 |
| 1Y | 45.94 | 2025-11-10 | -11.43% | 0.975 |
| 2Y | 109.09 | 2024-11-11 | -62.70% | — |
| 5Y | 56.36 | 2021-11-10 | -27.80% | 0.672 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $40.69, and today's volume is 4,937,637. NVO is down 1.667% today. The 30 day average volume is 11.89M. NVO market cap is $179.41B with 4.41B shares outstanding.